Clomiphene Citrate Stair-Step Protocol

Last updated: June 26, 2018
Sponsor: Ain Shams Maternity Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

Polycystic Ovarian Syndrome

Reproductive Health

Treatment

N/A

Clinical Study ID

NCT03178500
STAIRSTEP TRIAL
  • Ages 20-35
  • Female
  • Accepts Healthy Volunteers

Study Summary

A RCT will be conducted to compare the traditional clomiphene citrate regimens for ovulation induction with the stair-step protocol. Sixty women will be included after obtaining their written informed consent and will be randomized into either of the 2 groups.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age between 20-35 years.

  • Body mass index (BMI/m2) 26-35 kg/m2

  • Normal hystrosalpingogram (HSG).

  • Normal Prolactin level.

  • Normal semen analysis.

Exclusion

Exclusion Criteria:

    • They underwent ovarian drilling.

  • Other factors infertility.

  • AUTOimmune diseases as thyroid disorders and systemic lupus erythematosus.

Study Design

Total Participants: 60
Study Start date:
February 01, 2017
Estimated Completion Date:
July 31, 2018

Study Description

This study is a randomized clinical trial (RCT) will be conducted in Ain Shams University maternity hospital at infertility clinic within a period of 6-8 months.

All patient are previously diagnosed as PCOs according to the Rotterdam conference of 2003.

All patients will be devided according to computer based program into two groups First group: Patients with traditional protocol

Traditional protocol:

Clomiphene citrate (clomid) (50mg) will be given for 5 days (days 3-7). Transvaginal ultrasound from 9th-20th every other day if ovulation occur the patient will be excluded if no ovulation, we will wait for the next menses and increase the dose to (100mg). if no ovulation occurred increase the dose to (150mg) in the next cycle if no ovulation increase the dose to (200mg) TVUS from 9th-20th ovary other day. If no ovulation we will wait for next cycle and increase the dose to (250mg) and so till 6 cycles .

Second group: Patient with stair step protocol Follicular development will be monitored using transvaginal ultrasound at 11-14 day after (50mg) clomiphene for 5 days if there is no response (no follicle >10mm), so, (100mg) clomiphene will be initiated immediately for 5 days and ultrasound will be repeated 1 week after the first ultrasound. If there is no response, (150mg) clomiphene will be initiated immediately for another 5 days and TV/US will be performed 1 week after the second TV/US .

Connect with a study center

  • Ain Shams University Maternity Hospital

    Cairo,
    Egypt

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.